EUVIMEDEUVIMED entdecken
Crossref

SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms

The Egyptian Journal of Hospital Medicine · 01.01.2026 · 102 (1) · 1441-1447

DOI: 10.21608/ejhm.2026.493011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.01.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms. The Egyptian Journal of Hospital Medicine, 102(1), 1441-1447. https://doi.org/10.21608/ejhm.2026.493011

Vancouver

SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms. The Egyptian Journal of Hospital Medicine. 2026;102(1):1441-1447. doi:10.21608/ejhm.2026.493011

BibTeX
@article{euvimed2026,
  title = {SGLT2 Inhibitors and Myocardial Infarction in Diabetes: Current Insights into Cardioprotective Mechanisms},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {102},
  number = {1},
  pages = {1441--1447},
  doi = {10.21608/ejhm.2026.493011}
}
Kostenlos starten →